Results 231 to 240 of about 21,604,258 (289)
Advances and challenges of chimeric antigen receptor T cell therapy in digestive system malignancies. [PDF]
Wang C +4 more
europepmc +1 more source
Summary Treatment for plasma cell dyscrasias imposes burdens on patients and caregivers, particularly for cellular therapies. Traditional social determinants of health may not capture caregiver availability. We conducted a cross‐sectional survey through HealthTree.
Ghulam Rehman Mohyuddin +12 more
wiley +1 more source
The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapy. [PDF]
Lasocki A +3 more
europepmc +1 more source
Efficacy and safety of chimeric antigen receptor T-cell therapy in primary central nervous system lymphoma: a systematic review and meta-analysis. [PDF]
Al-Mashdali AF +7 more
europepmc +1 more source
Cytokine-Engineered Chimeric Antigen Receptor-T Cell Therapy: How to Balance the Efficacy and Toxicity. [PDF]
Zhang X +7 more
europepmc +1 more source
Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu +6 more
wiley +1 more source
Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy. [PDF]
Tashiro Y +11 more
europepmc +1 more source

